Group Leader Position on Synthetic Bioengineering at CIC biomaGUNE

The Center for Cooperative Research in Biomaterials, CIC biomaGUNE, together with Ikerbasque, invites applications for a Group Leader position in Synthetic Bioengineering for biomedical applications.
We are looking for candidates with a strong track record in the broad field of Biomaterials Engineering. Experience in the design of biomaterials, bioprinting, flexible materials, artificial scaffolds, and 3D functional engineered models, aiming at the understanding and control of the material properties for biomedical applications will be valued.
The successful candidate must have an established record of excellence in research in this area and is expected to develop an internationally recognized, externally funded research program that complements and/or extends the strengths of CIC biomaGUNE, to build internal and external collaborations, to mentor graduate students and postdocs, and to generate and transfer technology. We particularly invite scientists interested in translational research who aim at making a definitive clinical impact. Thus, a track record of successful collaboration with industry and clinicians will be positively evaluated.

Candidates should submit the following information before August 15, 2024 in this link:

  • Cover Letter
  • Curriculum Vitae
  • Detailed description of research interests and research plan
  • Contact information of three colleagues who can provide reference letters
  • Please note the deadline of the Ikerbasque call is September 12, 2024 at 13:00 CET.
    Only researchers with a strong record of research and group-leading experience, with a demonstrated record of scholarly excellence illustrated by the publication of influential research papers and a record of substantial external funding will be considered for a permanent Ikerbasque Professor or Associate position. Applications from younger researchers may be considered for an Ikerbasque Fellow tenure-track position. Women candidates are particularly welcome.

Full information here.